Innopharmascreen

Kyrgyzstan
Kyzyl-Suu, Issyk-Kul, Kyrgyzstan, 22007

Company profile

Innopharmascreen company profile

Innopharmascreen develops a protein chip-based, AI-aided drug discovery platform built to find novel drugs for a selected target. The company focuses on assisting in novel drug discovery through its technology, which is based on a protein-protein interaction assay system and an antibody microarray-based mode of action, helping pharmaceutical and biotechnology companies discover new drugs.

Business identity

Contact email
[email protected]
Phone number
+82-(0)32-834-8321
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01

Headquarters

Postal code
22007
Country code
KG
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$5M
Last funding
Series A / $1.8M / 2020-12-10
Last equity funding
Series A / $1.8M
Investors
4
Articles
3

Founders and investors

Investors

Aju IB InvestmentCapstone PartnersKDB CapitalMagna Investment